相关实验视频
Updated: Jul 12, 2025

10:37
Ferric Chloride-induced Murine Thrombosis Models
Published on: September 5, 2016
21.7K
[获得性血栓性血栓性缺血紫外线的新型治疗策略]
1Departments of Hematology and Blood Transfusion Medicine, Nara Medical University.
[Rinsho ketsueki] The Japanese journal of clinical hematology
|October 29, 2023
概括
血栓性血栓塞性紫外线 (TTP) 是一种严重的疾病. 像caplacizumab这样的新疗法提供了希望,可能减少未来需要血交换的需要.
科学领域:
- 血液学 血液学 血液学
- 免疫学 免疫学 免疫学
- 血管生物学 血管生物学
背景情况:
- 血栓性血栓细胞缺陷性紫外线 (TTP) 是一种由微血管血小板血栓形成的严重疾病.
- 获得性TTP是一种自身免疫性疾病,涉及对ADAMTS13的自身抗体,ADAMTS13是分裂威尔布兰德因子 (VWF) 的关键酶.
- 这导致ADAMTS13活性和疾病表现显著降低.
研究的目的:
- 审查当前对血栓性血栓细胞缺陷性紫外线 (TTP) 的理解和治疗情况.
- 突出TTP治疗的最新进展,包括卡普拉西祖马布和潜在的未来治疗方法.
主要方法:
- 对TTP的历史和当前治疗方式的审查.
- 讨论血交换,皮质类固醇和新疗法的作用.
- 检查正在进行的TTP临床试验,包括复合ADAMTS13产品.
主要成果:
- 自1991年以来,与新鲜冷血进行血交换一直是标准的TTP治疗方法.
- 针对VWF的单克隆抗体Caplacizumab于2022年开始使用,增加了治疗选择.
- 针对先天性TTP,正在进行复合ADAMTS13的临床试验.
结论:
- 血交换和皮质类固醇仍然是日本获得的TTP的标准护理.
- 卡普拉西祖马布代表了TTP管理的重大进步.
- 未来的疗法,如复合ADAMTS13,可能会消除在TTP治疗中需要血交换的需要.
相关概念视频
Venous Thrombosis III: Interprofessional Care
10
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
10
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
10
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
10
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
537
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
537
Peripheral Artery Disease III: Interprofessional Care
11
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
11
Anticoagulant Drugs: Low-Molecular-Weight Heparins
723
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
723
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.2K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.2K

